Topics

"ubiquitin ligase TRIM7 suppressed hepatocellular carcinoma progression directly" Drugs and Medication Database

14:21 EST 25th January 2020 | BioPortfolio

Here are the most relevant "ubiquitin ligase TRIM7 suppressed hepatocellular carcinoma progression directly" Drugs and Medications that we have found in our database.

More Information about "ubiquitin ligase TRIM7 suppressed hepatocellular carcinoma progression directly" on BioPortfolio

We have published hundreds of ubiquitin ligase TRIM7 suppressed hepatocellular carcinoma progression directly news stories on BioPortfolio along with dozens of ubiquitin ligase TRIM7 suppressed hepatocellular carcinoma progression directly Clinical Trials and PubMed Articles about ubiquitin ligase TRIM7 suppressed hepatocellular carcinoma progression directly for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ubiquitin ligase TRIM7 suppressed hepatocellular carcinoma progression directly Companies in our database. You can also find out about relevant ubiquitin ligase TRIM7 suppressed hepatocellular carcinoma progression directly Drugs and Medications on this site too.

Showing "ubiquitin ligase TRIM7 suppressed hepatocellular carcinoma progression directly" Drugs and Medications 1–25 of 146

Possibly Relevant

Keytruda [merck sharp & dohme corp.]

These highlights do not include all the information needed to use KEYTRUDA safely and effectively. See full prescribing information for KEYTRUDA. KEYTRUDA(pembrolizumab) for injection, for intravenous use KEYTRUDA(pembrolizumab) injection, for intravenous

Stivarga [bayer healthcare pharmaceuticals inc.]

These highlights do not include all the information needed to use STIVARGA safely and effectively. See full prescribing information for STIVARGA.STIVARGA® (regorafenib) tablets, for oral useInitial U.S. Approval: 2012

Tivicay [a-s medication solutions]

These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY.TIVICAY (dolutegravir) tablets, for oral useInitial U.S. Approval: 2013

Mvasi [amgen inc]

These highlights do not include all the information needed to use MVASI safely and effectively. See full prescribing information for MVASI .     MVASI (bevacizumab-awwb ) Solution for intravenous infusion Initial U.S. Approval: 2017 MVASI (bevacizumab-

Tivicay [doh central pharmacy]

These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY.TIVICAY (dolutegravir tablets), for oral useInitial U.S. Approval: 2013

Tivicay [viiv healthcare company]

These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY.TIVICAY (dolutegravir tablets), for oral useInitial U.S. Approval: 2013

Tivicay [remedyrepack inc.]

These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir tablets), for oral use Initial U.S. Approval: 2013

Sutent [pfizer laboratories div pfizer inc]

These highlights do not include all the information needed to use SUTENT safely and effectively. See full prescribing information for SUTENT. SUTENT (sunitinib malate) capsules, for oral useInitial U.S. Approval: 2006

Testosterone cypionate [physicians total care, inc.]

Testosterone Cypionate Injection, USP100 mg/mL and 200 mg/mL

Testosterone cypionate [physicians total care, inc.]

Testosterone Cypionate Injection, USP

Testosterone cypionate [dispensing solutions, inc.]

TESTOSTERONE CYPIONATE INJECTION USP FOR INTRAMUSCULAR USE ONLY C-III Rx only

Depo-testosterone [physicians total care, inc.]

Depo-Testosteronetestosterone cypionate injection, USP    CIII

Restasis [physicians total care, inc.]

RESTASIS (cyclosporine ophthalmic emulsion) 0.05%

Complera [remedyrepack inc.]

These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. COMPLERA (emtricitabine, rilpivirine, tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Appro

Nexavar [bayer healthcare pharmaceuticals inc.]

These highlights do not include all the information needed to use NEXAVAR safely and effectively.See full prescribing information for NEXAVAR.NEXAVAR (sorafenib) tablets, oral Initial U.S. Approval: 2005

Complera [a-s medication solutions]

These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. COMPLERA (emtricitabine, rilpivirine, tenofovir disoproxil fumarate) tablets, for oral useInitial U.S. Approv

Complera access [gilead sciences, inc.]

These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. COMPLERA™ (emtricitabine, rilpivirine, tenofovir disoproxil fumarate) tablets, for oral use GILEAD ACCESS P

Restasis [a-s medication solutions]

These highlights do not include all the information needed to use RESTASIS   0.05% safely and effectively. See full prescribing information for RESTASIS .       RESTASIS ( cyclosporine ophthalmic emulsion ) 0.05% For topical ophthalmic use Initial U

Descovy [remedyrepack inc.]

These highlights do not include all the information needed to use DESCOVY safely and effectively. See full prescribing information for DESCOVY. DESCOVY (emtricitabine and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2015

Descovy [gilead sciences, inc.]

These highlights do not include all the information needed to use DESCOVY safely and effectively. See full prescribing information for DESCOVY. DESCOVY (emtricitabine and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2015

Topotecan [teva parenteral medicines, inc.]

These highlights do not include all the information needed to use TOPOTECAN INJECTION safely and effectively. See full prescribing information for TOPOTECAN INJECTION. TOPOTECAN injection, for intravenous use Initial U.S. Approval: 1996

Testopel [slate pharma]

NA

Oxandrolone [par pharmaceutical, inc.]

Oxandrolone Tablet, USP

Oxandrolone [bryant ranch prepack]

Oxandrolone Tablet, USP

Restasis [allergan, inc.]

These highlights do not include all the information needed to use RESTASIS   0.05% safely and effectively. See full prescribing information for RESTASIS .       RESTASIS ( cyclosporine ophthalmic emulsion ) 0.05% For topical ophthalmic use Initial U



Quick Search